chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Vaccination site pain
Clinical narrative: Swollen lymph nodes in neck; Soreness at injection site; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The medical history included sarcoidosis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included pramipexole(MANUFACTURER UNKNOWN)  for an unknown indication from an unknown date and unknown if ongoing. On 08Apr2021 at 12:00, the patient experienced swollen lymph nodes in neck, soreness at injection site, headache and fatigue. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes in neck, soreness at injection site, headache and fatigue were resolving at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 28Apr2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash, Skin discolouration, Swelling
Clinical narrative: Rash on toes; Starred as swelling; Starred as swelling and blisters; Faded to blisters and discoloration; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 16:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 16:00, the patient experienced rash on toes. It started as swelling and blisters. It then faded to blisters and discoloration. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events rash on toes; started as swelling and blisters; faded to blisters and discoloration was resolved with sequelae on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Rash macular, Urticaria
Clinical narrative: Extensive rash/hives across hip and pubic areas; Spotty rash on thighs, chest, face; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 04May2021 at 20:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included losartan (MANUFACTURER UNKNOWN), probiotics nos (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN) all taken for an unknown indication from an unspecified date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 15:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 20:00, the patient experienced extensive rash/hives across hip and pubic areas and spotty rash on thighs, chest and face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with prednisone(MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extensive rash/hives across hip and pubic areas and spotty rash on thighs, chest and face were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: Bad headache 3 days after; Up to 102 fever; Aches all over; Chills; Extreme fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01May2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01May2021 at 16:30, the patient experienced up to 102 fever, aches all over, chills and extreme fatigue for 24 hours starting 8 hours after vaccine. On the same day, the patient underwent body temperature test and the result was up to 102 (unspecified units).  On 04May2021, the patient experienced bad headache 3 days after. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme up to 102 fever, aches all over, chills and extreme fatigue was resolved on 02May2021 and bad headache was resolved on an unknown date in May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Bad headache 3 days after; Up to 102 fever; Aches all over; Chills; Extreme fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01May2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01May2021 at 16:30, the patient experienced up to 102 fever, aches all over, chills and extreme fatigue for 24 hours starting 8 hours after vaccine. On the same day, the patient underwent body temperature test and the result was up to 102 (unspecified units).  On 04May2021, the patient experienced bad headache 3 days after. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme up to 102 fever, aches all over, chills and extreme fatigue was resolved on 02May2021 and bad headache was resolved on an unknown date in May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: Body felt like "I" was getting over Flu; Easily out of breathe; Nausea and vomiting started wednesday at 6 am; Vomiting started wednesday at 6 am; could not hold down anything.; Body aches; Exhaustion/ body drained and was overexerted easily; Woke up at midnight freezing with chills/shivering and could not warm up; Ran 100 plus fever from then until 7pm Wednesday.; After a few hours after vaccine, had headache; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 04May2021 at 10:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 13Apr2021 at 10:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 14:00, the patient experienced headache. On 05May2021 at 00:00, the patient woke up at midnight freezing with chills/shivering, could not warm up, ran 100 plus fever from then until 19:00 Wednesday. On 05May2021 at 06:00, the patient had nausea, vomiting and could not hold down anything. On 05May2021, the patient had body aches and exhaustion. On 06May2021, Thursday, the patient's body felt like getting over flu; body drained, was overexerted easily and out of breath. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 00:00, the patient underwent body temperature test and the result was 100 plus (units unspecified). The clinical outcome of the event ran 100 plus fever was resolved on 05May2021 at 19:00. The clinical outcome of the events headache, woke up at midnight freezing with chills/shivering, could not warm up, nausea, vomiting, could not hold down anything, body aches, exhaustion, body felt like getting over flu; body drained, was overexerted easily and out of breath was resolved on an unknown date in May2021.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Body felt like "I" was getting over Flu; Easily out of breathe; Nausea and vomiting started wednesday at 6 am; Vomiting started wednesday at 6 am; could not hold down anything.; Body aches; Exhaustion/ body drained and was overexerted easily; Woke up at midnight freezing with chills/shivering and could not warm up; Ran 100 plus fever from then until 7pm Wednesday.; After a few hours after vaccine, had headache; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 04May2021 at 10:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 13Apr2021 at 10:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 14:00, the patient experienced headache. On 05May2021 at 00:00, the patient woke up at midnight freezing with chills/shivering, could not warm up, ran 100 plus fever from then until 19:00 Wednesday. On 05May2021 at 06:00, the patient had nausea, vomiting and could not hold down anything. On 05May2021, the patient had body aches and exhaustion. On 06May2021, Thursday, the patient's body felt like getting over flu; body drained, was overexerted easily and out of breath. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 00:00, the patient underwent body temperature test and the result was 100 plus (units unspecified). The clinical outcome of the event ran 100 plus fever was resolved on 05May2021 at 19:00. The clinical outcome of the events headache, woke up at midnight freezing with chills/shivering, could not warm up, nausea, vomiting, could not hold down anything, body aches, exhaustion, body felt like getting over flu; body drained, was overexerted easily and out of breath was resolved on an unknown date in May2021.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: Minor Arm Pain; Aches; Chills; High fever; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 15Apr2021 at 07:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 19:30, the patient experienced minor arm pain, aches, chills and high fever. On the same day, the patient underwent body temperature test and the result was 102.7(unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event minor arm pain, aches, chills and high fever was resolved on an unknown date in 2021. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 06May2021 at 07:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache, Malaise, Myalgia, Nausea
Clinical narrative: Fever; Body aches; Body aches especially in the lower back region; Muscle soreness; Nausea; Nausea which led to vomiting; Headache; All over ill feeling; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 07May2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disorder, osteoarthritis, joint replacement, cataracts, glaucoma and known allergies to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) and paracetamol (TYLENOL EXTRA-STRENGTH); both were taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration on 16Apr2021 at 16:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 22:00, the patient experienced fever, body aches especially in the lower back region, muscle soreness, nausea which led to vomiting, headache and all-over ill feeling. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events fever, body aches, body aches especially in the lower back region, muscle soreness, nausea, nausea which led to vomiting, headache and all-over ill feeling was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vomiting
Clinical narrative: Fever; Body aches; Body aches especially in the lower back region; Muscle soreness; Nausea; Nausea which led to vomiting; Headache; All over ill feeling; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 07May2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disorder, osteoarthritis, joint replacement, cataracts, glaucoma and known allergies to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) and paracetamol (TYLENOL EXTRA-STRENGTH); both were taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration on 16Apr2021 at 16:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 22:00, the patient experienced fever, body aches especially in the lower back region, muscle soreness, nausea which led to vomiting, headache and all-over ill feeling. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events fever, body aches, body aches especially in the lower back region, muscle soreness, nausea, nausea which led to vomiting, headache and all-over ill feeling was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test, Tinnitus
Clinical narrative: Headache; Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CP7534) via an unspecified route of administration in the left arm on 18Mar2021 at 16:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, blood pressure high (bp/high), cholesterol and herniated disc. The patient did not receive any medication within two weeks of vaccination. The patient received concomitant medications within two weeks of vaccination, but were unspecified. The patient previously received cefdinir (OMNICEF) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 17:45, within an hour of vaccine, the patient had a severe headache and ears started ringing. The headache went away by next morning but ears were still ringing almost two months later. Therapeutic measured were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 23Apr2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The clinical outcome of the event headache was resolved on 19Mar2021 while that of ringing in ears was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Pain under arm down side after 2nd dose; This is a spontaneous report from a contactable consumer. A female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown if the patient was pregnant at the time of vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any concomitant medications. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, after 2nd dose, the patient experienced pain under arm down side. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event pain under arm down side after 2nd dose was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes under armpit; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 07May2021 at 08:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 15Apr2021 at 08:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08May2021 at 17:00, the patient experienced swollen lymph nodes under armpit. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes under armpit was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Constipation, Dehydration, Fatigue, Flatulence, Headache
Clinical narrative: Nauseous, since the Pfizer vaccine was injected into me; Burning sensation in my throat area, almost like heartburn; Feel unwell; Constipated; Gassy; Overly dehydrated, its like no matter how much I hydrate my pallet seems dry; Slight headache; Tired a lot; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06May2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. Concomitant medications were not reported. On 06May2021 at 14:30, since the Pfizer vaccine was injected, the patient was nauseous, had almost like a burning sensation in throat area, almost like heartburn, also felt unwell, constipated and gassy. The patient was overly dehydrated, it's like no matter how much she hydrate her pallet seems dry, had a slight headache on the first day but that went away, was tired a lot. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nauseous was not recovered whereas burning sensation in throat area, almost like heartburn, feel unwell, constipated, gassy and the overly dehydrated, like no matter how much hydrated pallet seems dry and tired a lot was unknown at the time of report while slight headache was recovered on an unknown date in May2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Throat irritation
Clinical narrative: Nauseous, since the Pfizer vaccine was injected into me; Burning sensation in my throat area, almost like heartburn; Feel unwell; Constipated; Gassy; Overly dehydrated, its like no matter how much I hydrate my pallet seems dry; Slight headache; Tired a lot; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06May2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. Concomitant medications were not reported. On 06May2021 at 14:30, since the Pfizer vaccine was injected, the patient was nauseous, had almost like a burning sensation in throat area, almost like heartburn, also felt unwell, constipated and gassy. The patient was overly dehydrated, it's like no matter how much she hydrate her pallet seems dry, had a slight headache on the first day but that went away, was tired a lot. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nauseous was not recovered whereas burning sensation in throat area, almost like heartburn, feel unwell, constipated, gassy and the overly dehydrated, like no matter how much hydrated pallet seems dry and tired a lot was unknown at the time of report while slight headache was recovered on an unknown date in May2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Oropharyngeal pain
Clinical narrative: Sore throat; Difficult to swallow; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 at 12:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), atorvastatin calcium (LIPITOR), gliclazide (CLARITIN), modafinil (MANUFACTURER UNKNOWN) and anastrozole (ANASTRAZ) all were taken for an unknown indication from an unknown date and unknown if ongoing. On 06May2021 at 15:00, the patient experienced sore throat and difficult to swallow and the event was ongoing 48 hours after shot. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat and difficult to swallow were not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hypohidrosis, Rash, Rash erythematous, Rash pruritic, Skin abrasion
Clinical narrative: Within 2-3 weeks I developed a puritic, excoriating red rash to both underarm areas.; a puritic, excoriating red rash to both underarm areas.; a puritic, excoriating red rash to both underarm areas.; No longer sweat (minimally only) or smell. I no longer need to use deodorant; I did have a rash to my shin areas as well bilaterally which resolved on its own.; This is a spontaneous report from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on unknown date in Jan2021 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included lynch syndrome carrier (MSH2). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not provided. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an unspecified route of administration in the right arm on 21Dec2020 (at the age of 41-year-old), as a single dose. On 31Jan2021, within 2-3 weeks, the patient developed a pruritic, excoriating red rash to both underarm areas. The rash did not improve with steroid creams or antifungals. The rash continued for 4-6 weeks and required steroids to resolve. As of today (as reported), the rash had resolved but patient no longer sweat (minimally only) or smell and no longer needed to use deodorants. The patient also had a rash to shin areas as well bilaterally which resolved on its own. One week ago (as reported), the patient developed a pruritic rash to right hip area which patient found as a strange reaction. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with steroid creams or antifungals and tapered steroid prescription (not specified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pruritic, excoriating red rash to both underarm areas, rash to my shin areas as well bilaterally and pruritic rash to my right hip area was resolved with lasting effects on an unknown date in 2021. The clinical outcome of the events no longer sweat (minimally only) or smell was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia, Rash
Clinical narrative: Low fever; nose blockage; skin rash which last weeks so far; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 10:45 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy (unspecified allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive other medications within 2 weeks of vaccination. On 17Apr2021 at 12:00, the patient experienced low fever, nose blockage and skin rash which last weeks so far. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events low fever, nose blockage, skin rash which last weeks so far was resolving at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 10:45 (at the age of 48-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Felt sick after second shot; This is a spontaneous report from a non-contactable consumer. A male patient of unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. On an unknown date, after second shot, the patient felt sick. The clinical outcome of the event felt sick was unknown at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, SARS-CoV-2 test
Clinical narrative: Red rash; Red rash arm very itchy after second dose; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive have any concomitant medications within two weeks of the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021, the patient started to have red rash and arm was very itchy after second dose. Approximately after 10 days of second shot, the patient's right arm started to get a rash as well but left arm was worse. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. On 23Apr2021, the patient underwent COVID-19 PCR test (nasal swab) and the result was negative. Therapeutic measures were taken as a result of the event which included treatment with betamethasone acetate and betamethasone sodium phosphate (CELESTONE CHRONODOSE) ampule from an unknown start date. The clinical outcome of the events red rash and arm very itchy was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Vomiting
Clinical narrative: Next morning had chills; Aching; Vomited; Day of vaccine sore arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 07May2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 16Apr2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 07May2021, on the day of vaccination, the patient experienced sore arm. On 08May2021 at 07:00, when the patient woke up next morning, the patient experienced chills, aching and vomited. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events day of vaccine sore arm, and the patient woke up with chills, aching and vomited was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure measurement, Headache, Heart rate, Heart rate increased
Clinical narrative: Drop in BP; Increase heart rate; Severe headache; Slight rash on forearms; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 02:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to dust, mold, grass, animals and aloe and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (ALAVERT), taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin; clavulanic acid (AUGMENTIN) and levofloxacin (LEVOQUIN) and experienced drug allergy. On 21Apr2021, 4 days after the vaccination, the patient experienced slight rash on forearms. On 01May2021 and 02May2021, 14 and 15 days after the vaccination, the patient experienced severe headache. On 03May2021, 16 days after the vaccination, the patient experienced drop in blood pressure (BP) and increase heart rate. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight rash on forearms was resolved on an unknown date in 2021 while severe headache, drop in BP and increase heart rate was resolved on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Drop in BP; Increase heart rate; Severe headache; Slight rash on forearms; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 02:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to dust, mold, grass, animals and aloe and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (ALAVERT), taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin; clavulanic acid (AUGMENTIN) and levofloxacin (LEVOQUIN) and experienced drug allergy. On 21Apr2021, 4 days after the vaccination, the patient experienced slight rash on forearms. On 01May2021 and 02May2021, 14 and 15 days after the vaccination, the patient experienced severe headache. On 03May2021, 16 days after the vaccination, the patient experienced drop in blood pressure (BP) and increase heart rate. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight rash on forearms was resolved on an unknown date in 2021 while severe headache, drop in BP and increase heart rate was resolved on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Insomnia, Tachyphrenia
Clinical narrative: This is a spontaneous report from a contactable consumer. A 60-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 60, via an unspecified route of administration, on an unknown date in Apr 2021, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. Prior to the vaccination, patient was not diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr 2021, patient experienced 15 hours of sleeplessness, head racing and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, it was unknown whether the patient has tested for COVID-19. The outcome of 15 hours of sleeplessness, head racing and anxiety resolved on an unknown date in 2021. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Rash on neck and chest, very itchy, appeared 3 days after both shots. This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 13:45 (at the age of 64-years-old) and  second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 04May2021 at 14:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The medical history included high blood pressure, thyroid disease, high cholesterol and allergy to NSAIDS, sulfa and some penicillins. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included irbesartan (AVAPRO), levothyroxine (MANUFACTURER UNKNOWN), lovastatin (MANUFACTURER UNKNOWN) and fish oil (OMEGA 3); all from unknown dates for unknown indications and unknown if ongoing. The patient previously took clarithromycin (CLARET) on an unknown date and experienced allergy. On 16Apr2021, the patient experienced rash on neck and chest, very itchy, which appeared 3 days after both shots. The patient reported that she used steroid cream Triamcinolone Acet 0.1% CR and the rash went away after 7 days. Therapeutic measures were taken as a result of the reported events which included treatment with triamcinolone acetonide cream (MANUFACTURER UNKNOWN). The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on neck and chest, very itchy  was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Pain in extremity
Clinical narrative: Extreme pain in upper arm, can not lift arm up at all; Extreme pain in upper arm, can not lift arm up at all; This is a spontaneous report from a contactable pharmacist, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 07May2021 at 19:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 08May2021, the patient experienced extreme pain in upper arm, could not lift arm up at all. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme pain in upper arm, can not lift arm up at all was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: About an hour after the vaccine couldnt turn head to the left. It lasted for about 4 hours and then went away.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613) via an unspecified route of administration in the left arm on 05May2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy, bipolar disorder, high blood pressure, high cholesterol and known allergies to NSAIDS. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included topiramate (TOPAMAX), gabapentin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN), clopidogrel bisulfate (PLAVIX), escitalopram oxalate (LEXAPRO) and trihexyphenidyl hydrochloride/chlorpromazine hydrochloride/trifluoperazine hydrochloride (SER); all taken for unknown indications from an unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 13:00 the patient experienced about an hour after the vaccine could not turn her head to the left, lasted for about 4 hours and then went away. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event about an hour after the vaccine could not turn head to the left, lasted for about 4 hours and then went away was resolved on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.